LON:HZD - Horizon Discovery Group Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started GBX 164 -2.00 (-1.20 %) (As of 02/22/2019 04:00 PM ET)Previous CloseGBX 164Today's RangeGBX 162 - GBX 16452-Week RangeGBX 160 - GBX 294Volume29,318 shsAverage Volume258,981 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Horizon Discovery Group plc, an integrated life science company, designs, manufactures, and applies gene editing and gene modulation to build cell models that harbour the genetics of human disease in the Americas, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company operates through Products, Services, and Leveraged Research and Development (R&D) segments. Its core capabilities are built around its proprietary transnational genomics platform, a suite of gene editing tools to alter gene sequence in human or mammalian cell-lines. The company offers various research products, including cell lines that help researchers to understand how complex genetic diseases manifest themselves in patients; research reagents, which enable researchers to silence genes with the use of RNAi and express or overexpress genes through tools, such as cDNA, as well as permanently edit genes with CRISPR reagents; and in vivo research models for specialized R&D applications, and to support preclinical drug development programs. It also provides reference standards that are used as a source of genetically defined, quantitative, sustainable, and independent third-party reference material, as well as for validation and routine performance monitoring of assays; and bio-production cell lines licenses. In addition, the company offers cell and in vivo custom model generation, assay, and genetic and molecular screening services, as well as screening publications. Further, it is involved in the leverages R&D activity. The company serves customers in academic research, drug discovery and manufacturing, and clinical diagnostics markets. It sells its products through direct sales channel and e-commerce platform. The company has a target discovery partnership with C4X Discovery Holdings plc to validate novel synthetic oncology targets. Horizon Discovery Group plc was founded in 2007 and is headquartered in Cambridge, the United Kingdom. Receive HZD News and Ratings via Email Sign-up to receive the latest news and ratings for HZD and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:HZD Previous Symbol CUSIPN/A CIKN/A Webwww.horizondiscovery.com Phone+44-1223-976000Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees288 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Horizon Discovery Group (LON:HZD) Frequently Asked Questions What is Horizon Discovery Group's stock symbol? Horizon Discovery Group trades on the London Stock Exchange (LON) under the ticker symbol "HZD." What price target have analysts set for HZD? 2 Wall Street analysts have issued twelve-month price targets for Horizon Discovery Group's shares. Their predictions range from GBX 177 to GBX 245. On average, they expect Horizon Discovery Group's stock price to reach GBX 211 in the next twelve months. This suggests a possible upside of 28.7% from the stock's current price. View Analyst Price Targets for Horizon Discovery Group. What is the consensus analysts' recommendation for Horizon Discovery Group? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Horizon Discovery Group in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Horizon Discovery Group. Has Horizon Discovery Group been receiving favorable news coverage? Headlines about HZD stock have been trending negative this week, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Horizon Discovery Group earned a coverage optimism score of -2.1 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. Who are some of Horizon Discovery Group's key competitors? Some companies that are related to Horizon Discovery Group include 4d Pharma (DDDD), Abattis Bioceuticals (ATTBF), Abcam (ABC), ABcann Global (ABCN), ABLYNX NV/ADR (ABLX), ABZENA/PAR VTG FPD 0.002 (ABZA), Almirall (LBTSF), AorTech International (AOR), Arix Bioscience (ARIX), Arno Therapeutics (ARNI), Axim Biotechnologies (AXIM), Biocure Technology (CURE), Biotest (BIO), Bioventix (BVXP) and BTG (BTG). What other stocks do shareholders of Horizon Discovery Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Horizon Discovery Group investors own include Yamana Gold (YRI), Silvercorp Metals (SVM), Barkerville Gold Mines (BGM), Polo Resources (POL), Faron Pharmaceuticals Oy (FARN), Eldorado Gold (ELD), Eastside Distilling (EAST), Red Rock Resources (RRR), First Majestic Silver (AG) and Alamos Gold (AGI). Who are Horizon Discovery Group's key executives? Horizon Discovery Group's management team includes the folowing people: Mr. Richard John Vellacott, CFO & Director (Age 44)Mr. Terence William Pizzie, CEO & Director (Age 58)Dr. Chris Torrance, Co-Founder & Member of Scientific Advisory BoardProf. Alberto Bardelli Ph.D., Co-Founder & Chairman of Scientific Advisory BoardMs. Kim Nichols, Head of Global Operations How do I buy shares of Horizon Discovery Group? Shares of HZD and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Horizon Discovery Group's stock price today? One share of HZD stock can currently be purchased for approximately GBX 164. What is Horizon Discovery Group's official website? The official website for Horizon Discovery Group is https://www.horizondiscovery.com/. How can I contact Horizon Discovery Group? Horizon Discovery Group's mailing address is 8100 Cambridge Research Park Beach Drive, CAMBRIDGE, CB25 9TL, United Kingdom. The company can be reached via phone at +44-1223-976000. MarketBeat Community Rating for Horizon Discovery Group (LON HZD)Community Ranking: 3.1 out of 5 ( )Outperform Votes: 398 (Vote Outperform)Underperform Votes: 253 (Vote Underperform)Total Votes: 651MarketBeat's community ratings are surveys of what our community members think about Horizon Discovery Group and other stocks. Vote "Outperform" if you believe HZD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HZD will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/23/2019 by MarketBeat.com StaffFeatured Article: What is Cost of Goods Sold (COGS)?